NYC.MD FDA Approvals...

Drug-Eluting Stent Approved for Peripheral Arterial Disease
Coated hollow tube props open thigh artery
Xeljanz Approved for Rheumatoid Arthritis
For people who can't take methotrexate
Xarelto's Approval Expanded
To include people with deep vein thrombosis or pulmonary embolism
FDA: More Tainted Products at Firm Tied to Meningitis Outbreak
Toll on Friday stood at 29 people dead, 404 sickened, officials report
FDA: Ameridose Issues Voluntary Recall of All Products
All unexpired products should be returned to manufacturer
Synribo Approved to Treat Rare Leukemia
If other treatments haven't stopped CML's progression
Fycompa Approved for Epileptic Seizures
Among people aged 12 and older
Approval Expanded for Sapien Artificial Heart Valve
More people with narrowed aortic valve are now eligible
Jetrea Approved to Treat Eye Condition
Symptomatic vitreomacular adhesion
Abraxane Approved to Treat Advanced Lung Cancer
Among people who aren't candidates for surgery or radiation
New Defibrillator Implanted Just Under the Skin
But it's still designed to correct an irregular heartbeat
Humira's Approval Widened to Include Ulcerative Colitis
Disease causes inflammation in large intestine
Stivarga Approved for Advanced Colorectal Cancer
Designed to block enzymes that encourage tumor growth
First Ultrasound to Spot Cancer in Dense Breasts Approved
Mammography will help doctors decide which women should get new screen
Aubagio Approved for Multiple Sclerosis
But label warns of possible liver problems, birth defects
Newly Approved Imaging Agent Helps Find Prostate Cancer
But not replacement for actual tissue testing, FDA says
Bosulif Approved for Rare Leukemia
Primarily caused by genetic mutation
Xtandi Approved for Advanced Prostate Cancer
Drug increased survival time for patients who'd failed hormone-based treatments
Sponsored By


Search FDA Approvals
by Keyword: